dc.contributor.author |
Garbe, Claus |
|
dc.date.accessioned |
2024-01-22T08:27:28Z |
|
dc.date.available |
2024-01-22T08:27:28Z |
|
dc.date.issued |
2023 |
|
dc.identifier.issn |
0959-8049 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/149397 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Oxford : Elsevier Sci Ltd |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1016/j.ejca.2023.05.003 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
Adjuvant therapy for stage II melanoma: the need for further studies |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20230928000000_00348 |
|
utue.personen.roh |
Lee, Rebecca |
|
utue.personen.roh |
Mandala, Mario |
|
utue.personen.roh |
V. Long, Georgina |
|
utue.personen.roh |
Eggermont, Alexander M. M. |
|
utue.personen.roh |
van Akkooi, Alexander C. J. |
|
utue.personen.roh |
Sandhu, Shahneen |
|
utue.personen.roh |
Garbe, Claus |
|
utue.personen.roh |
Lorigan, Paul |
|
dcterms.isPartOf.ZSTitelID |
European Journal of Cancer |
de_DE |
dcterms.isPartOf.ZS-Issue |
Article 112914 |
de_DE |
dcterms.isPartOf.ZS-Volume |
189 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |